Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial.

8 10 Although the increases in CD3, CD4 T-cell and PD-1 cell densities did not reach statistical significance, their elevated presence post-treatment suggests an overall shift toward a more active immune microenvironment.

also in 111,027 other papers